Skip to main content
. 2018 Sep 4;2018(9):CD013102. doi: 10.1002/14651858.CD013102

Andres 2007.

Methods Randomised trial
Participants 112 participants with type 2 diabetes (intervention 58; control 56)
144 community pharmacies in the province of Pontevedra
Spain
26 pharmacists
Year of study: February 2003 to March 2004.
Interventions Drug knowledge was assessed by pharmacists using the "Dáder" method (a process for pharmacist follow‐up of patients who are receiving medication).
Compliance with medication was assessed using a modified Morisky‐Green questionnaire.
Every 3 months
Duration 12 months
Outcomes HbA1C
Notes Published in Spanish
Funding source: Not specified
Conflict of interest: Not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information of randomisation procedure provided
Allocation concealment (selection bias) Unclear risk No relevant information found
Blinding of participants and personnel (performance bias) 
 All Outcomes/Outcome 1 High risk In this complex intervention, the personnel are unlikely to have been blinded; implications for performance bias are unclear
Blinding of outcome assessment (detection bias) 
 All Outcomes/Outcome 1 Low risk HBA1c is unlikely to be biased by outcome assessors
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Low dropout rate. Between group attrition < 10%.
Selective reporting (reporting bias) Low risk All main results reported
Other bias Low risk None